Skip to main content
A clinician at an intensive care workstation looking at two PainCube screens

StellarCube measures what cannot be seen.

A clinical decision support solution for pain prediction, PainCube.

JOINT RESEARCH

Joint research partners

PainCube is being developed through joint research with Johns Hopkins Medicine and Korea University Anam Hospital.

Data collection covers 32 beds at Johns Hopkins Medicine and 24 beds at Korea University Anam Hospital, spanning more than 12 types of biosignal and medical-record data.

  • Johns Hopkins Medicine

    Data collection32 beds

    SungMin ChoMHS

    Principal investigator, PainCube joint research

  • Korea University Anam Hospital

    Data collection24 beds

    Hee Jung KimPh.D.

    Principal investigator, PainCube joint research

PainCube Milestones

From Research to Global Expansion

Building on research, development and clinical collaboration, PainCube carries national R&D and global expansion forward to set a new standard for the future of pain management.

  1. 2025

    Global expansion
    • Hudson County Chamber of Commerce

      Participated in K-Bio NJ Summit 2025

  2. Joint research
    • Johns Hopkins Medicine

      IRB approval completed

  3. Joint research
    • Korea University Medicine Industry–Academic Cooperation Foundation

      Joint research and development contract completed

  4. 2026

    MOU
    • Korea University College of Medicine

      MOU signed

    • Johns Hopkins Medicine

      MOU signed

  5. Joint research
    • Korea University Anam Hospital

      IRB approval completed

    • Johns Hopkins Medicine

      Joint research and development contract completed

  6. Global expansion
    • Established StellarCube USA, a US subsidiary

  7. National R&D · Global expansion
    • Korea Technology and Information Promotion Agency for SMEs (TIPA)

      2026 TIPA Global Collaborative R&D Program (pre-planning) — developing a multimodal biosignal-based pain prediction and clinical decision support system

    • Seoul Business Agency (SBA)

      Selected for the Seoul Startup Boston Biohealth Global Expansion Program 2026

  8. Global expansion
    • KSEA

      Attended IES at UKC 2026

    • KSEA

      Reached the finals of the Start-up Pitch Competition

OUR GROWTH PATH

From data to AI, from AI to Healthcare

  1. DATA
  2. EXPERIENCE
  3. AI
  4. HEALTHCARE

We began with the work of turning scattered data into structured information, proved it across industries, moved on to AI analysis and prediction, and extended it into technology for human health.

See Traction